US5112824A
(en)
|
1989-12-08 |
1992-05-12 |
Merck & Co., Inc. |
Benzofuran compounds as class III antiarrhythmic agents
|
FR2665159B1
(fr)
|
1990-07-24 |
1992-11-13 |
Rhone Poulenc Sante |
Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
DE4212748A1
(de)
|
1992-04-16 |
1993-10-21 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
GB9420521D0
(en)
|
1994-10-12 |
1994-11-30 |
Smithkline Beecham Plc |
Novel compounds
|
GB9420999D0
(en)
|
1994-10-18 |
1994-12-07 |
Smithkline Beecham Plc |
Novel compounds
|
WO1996018617A1
(en)
|
1994-12-12 |
1996-06-20 |
Merck & Co., Inc. |
Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
|
GB9500580D0
(en)
|
1995-01-12 |
1995-03-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
TR199700749T1
(xx)
|
1995-02-02 |
1998-02-21 |
Smithkline Beecham P.L.C. |
5-HT resept�r antagonisti olarak indole t�revleri.
|
US5668148A
(en)
|
1995-04-20 |
1997-09-16 |
Merck & Co., Inc. |
Alpha1a adrenergic receptor antagonists
|
GB9517559D0
(en)
|
1995-08-26 |
1995-10-25 |
Smithkline Beecham Plc |
Novel compounds
|
US5886186A
(en)
|
1995-10-25 |
1999-03-23 |
Versicor, Inc. |
Synthesis of substituted N-heteroaromatic compounds and methods of use thereof
|
JP2000507590A
(ja)
|
1996-04-03 |
2000-06-20 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質トランスフェラーゼ阻害剤
|
US5872136A
(en)
|
1996-04-03 |
1999-02-16 |
Merck & Co., Inc. |
Arylheteroaryl inhibitors of farnesyl-protein transferase
|
FR2763944B1
(fr)
|
1997-06-03 |
2000-12-15 |
Centre Nat Rech Scient |
Nouveaux derives de coumarines, leurs procedes de preparation et leur application comme medicaments en tant qu'inhibiteurs de proteases
|
JPH1149676A
(ja)
|
1997-07-31 |
1999-02-23 |
Geron Corp |
ピリジン系テロメラーゼ阻害剤
|
JPH11209366A
(ja)
|
1998-01-23 |
1999-08-03 |
Nissan Chem Ind Ltd |
クロマン誘導体及び心不全治療薬
|
US6489344B1
(en)
|
1998-06-19 |
2002-12-03 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
AR019190A1
(es)
|
1998-07-08 |
2001-12-26 |
Sod Conseils Rech Applic |
Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
|
AU3876600A
(en)
|
1999-03-16 |
2000-10-04 |
Cytovia, Inc. |
Substituted 2-aminobenzamide caspase inhibitors and the use thereof
|
GB9922171D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
AU8645401A
(en)
|
2000-08-14 |
2002-02-25 |
Ortho Mcneil Pharm Inc |
Substituted pyrazoles
|
CA2421493A1
(en)
|
2000-09-06 |
2002-03-14 |
Ortho-Mcneil Pharmaceutical, Inc. |
A method for treating allergies using substituted pyrazoles
|
AU2001292276A1
(en)
|
2000-09-27 |
2002-04-08 |
Toray Industries, Inc. |
Nitrogen-containing compounds and ccr3 inhibitors containing the same as the active ingredient
|
HN2001000224A
(es)
|
2000-10-19 |
2002-06-13 |
Pfizer |
Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
|
US6710058B2
(en)
|
2000-11-06 |
2004-03-23 |
Bristol-Myers Squibb Pharma Company |
Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
|
KR20030059835A
(ko)
|
2000-12-07 |
2003-07-10 |
씨브이 쎄러퓨틱스, 인코포레이티드 |
관상동맥 질환 또는 동맥경화증에 대한 abca-1 상승화합물로서의 1,3,5-트리아진 및 피리미딘
|
WO2002053160A1
(en)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Method for treating glaucoma ivb
|
EP1679313A3
(en)
|
2001-02-21 |
2006-08-16 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
ATE409181T1
(de)
|
2001-05-08 |
2008-10-15 |
Univ Yale |
Proteomimetische verbindungen und verfahren
|
WO2003042190A1
(en)
|
2001-11-12 |
2003-05-22 |
Pfizer Products Inc. |
N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
JP2003192673A
(ja)
|
2001-12-27 |
2003-07-09 |
Bayer Ag |
ピペラジンカルボキシアミド誘導体
|
US7408067B2
(en)
|
2002-01-17 |
2008-08-05 |
Merck + Co., Inc. |
Aza-cyclic compounds as modulators of acetylcholine receptors
|
JP4167848B2
(ja)
|
2002-04-10 |
2008-10-22 |
広栄化学工業株式会社 |
ビアリール化合物の製造法
|
CN1181065C
(zh)
|
2002-05-08 |
2004-12-22 |
上海医药工业研究院 |
芳烷甲酰烷基哌嗪衍生物及其作为脑神经保护剂的应用
|
WO2004000820A2
(en)
|
2002-06-21 |
2003-12-31 |
Cellular Genomics, Inc. |
Certain aromatic monocycles as kinase modulators
|
AU2003249369A1
(en)
|
2002-06-21 |
2004-01-06 |
Cellular Genomics, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
BR0313397A
(pt)
|
2002-08-14 |
2005-06-28 |
Vertex Pharmaceuticals Incorpo |
Inibidores de proteina cinase e usos destes
|
AU2003302084A1
(en)
|
2002-11-15 |
2004-06-15 |
Bristol-Myers Squibb Company |
Open chain prolyl urea-related modulators of androgen receptor function
|
US20040248850A1
(en)
|
2003-02-11 |
2004-12-09 |
Kemia, Inc. |
Compounds for the treatment of HIV infection
|
CL2004000234A1
(es)
|
2003-02-12 |
2005-04-15 |
Biogen Idec Inc |
Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
|
DE602004017316D1
(de)
|
2003-07-24 |
2008-12-04 |
Euro Celtique Sa |
Heteroaryl-tetrahydropyridylverbindungen, die sich für die behandlung bzw. die prävention von schmerzen eignen
|
TWI287567B
(en)
|
2003-07-30 |
2007-10-01 |
Chi Mei Optoelectronics Corp |
Light-emitting element and iridium complex
|
JP2007501805A
(ja)
|
2003-08-08 |
2007-02-01 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ピリジルピペラジニルウレア
|
KR20060079190A
(ko)
|
2003-08-14 |
2006-07-05 |
아사히 가세이 파마 가부시키가이샤 |
치환 아릴알칸산 유도체 및 그의 용도
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
AU2004276337B2
(en)
|
2003-09-24 |
2009-11-12 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
WO2005079802A1
(en)
|
2004-02-12 |
2005-09-01 |
Merck & Co., Inc. |
Bipyridyl amides as modulators of metabotropic glutamate receptor-5
|
CA2561977A1
(en)
|
2004-03-30 |
2005-10-13 |
Chiron Corporation |
Substituted thiophene derivatives as anti-cancer agents
|
DE602005018758D1
(de)
|
2004-04-01 |
2010-02-25 |
Lilly Co Eli |
Am histamin-h3-rezeptor wirksame mittel, herstellung und therapeutische anwendungen
|
US7459562B2
(en)
|
2004-04-23 |
2008-12-02 |
Bristol-Myers Squibb Company |
Monocyclic heterocycles as kinase inhibitors
|
FR2869904B1
(fr)
|
2004-05-07 |
2006-07-28 |
Fournier S A Sa Lab |
Modulateurs des recepteurs lxr
|
WO2006019833A1
(en)
|
2004-07-26 |
2006-02-23 |
Eli Lilly And Company |
Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses
|
JP2008516989A
(ja)
|
2004-10-19 |
2008-05-22 |
コンパス ファーマシューティカルズ リミティド ライアビリティ カンパニー |
組成物及び抗腫瘍剤としてのその使用
|
WO2006051311A1
(en)
|
2004-11-12 |
2006-05-18 |
Galapagos Nv |
Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes
|
CA2588607A1
(en)
|
2004-11-23 |
2006-06-01 |
Ptc Therapeutics, Inc. |
Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
|
AR053992A1
(es)
|
2004-12-22 |
2007-05-30 |
Astrazeneca Ab |
Compuestos quimicos con actividad anticancerosa, un procedimiento para su preparacion, su uso en la preparacion de medicamentos y composicion farmaceutica.
|
AU2005317870A1
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Pyridine carboxamide derivatives for use as anticancer agents
|
PL2354126T3
(pl)
|
2005-01-14 |
2014-03-31 |
Chemocentryx Inc |
Sulfonamidy heteroarylowe i CCR2
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
EP1683796A1
(en)
|
2005-01-24 |
2006-07-26 |
Schering Aktiengesellschaft |
Pyrazolopyridines, their preparation and their medical use
|
EP1844003A4
(en)
|
2005-01-27 |
2010-09-22 |
Astrazeneca Ab |
NEW BIAROMATIC COMPOUNDS AS INHIBITORS OF THE P2X7 RECEPTOR
|
US7888374B2
(en)
|
2005-01-28 |
2011-02-15 |
Abbott Laboratories |
Inhibitors of c-jun N-terminal kinases
|
US20060178388A1
(en)
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
US20070135437A1
(en)
|
2005-03-04 |
2007-06-14 |
Alsgen, Inc. |
Modulation of neurodegenerative diseases
|
EP1879881A2
(en)
|
2005-04-14 |
2008-01-23 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
|
JP2008545624A
(ja)
|
2005-05-13 |
2008-12-18 |
チバ ホールディング インコーポレーテッド |
金属錯体を含むケラチン繊維を着色するための方法
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
WO2006130403A1
(en)
|
2005-06-02 |
2006-12-07 |
Bayer Cropscience Ag |
Phenylalkyl substituted heteroaryl devivatives
|
EP1893607A4
(en)
|
2005-06-09 |
2010-07-21 |
Merck Sharp & Dohme |
CHECKPOINT KINASE INHIBITORS
|
WO2006137772A1
(en)
|
2005-06-20 |
2006-12-28 |
Astrazeneca Ab |
New physical form of n,n´- disubstituted oxabispidines
|
DE602006011752D1
(de)
|
2005-06-24 |
2010-03-04 |
Bristol Myers Squibb Co |
Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
|
WO2007005510A1
(en)
|
2005-06-30 |
2007-01-11 |
Janssen Pharmaceutica N.V. |
N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
|
WO2007008541A2
(en)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc. |
Cellular cholesterol absorption modifiers
|
FR2892412B1
(fr)
|
2005-10-26 |
2008-05-16 |
Galderma Res & Dev |
Composes biaromatiques modulateurs des ppars
|
TW200804307A
(en)
|
2005-10-27 |
2008-01-16 |
Synta Pharmaceuticals Corp |
Process for preparing mesylate salts of IL-12 inhibitory compounds
|
JP2009514858A
(ja)
|
2005-11-03 |
2009-04-09 |
メルク エンド カムパニー インコーポレーテッド |
アリール−ピラゾリルモチーフを有するヒストンデアセチラーゼ阻害剤
|
SI2404919T1
(sl)
|
2005-11-08 |
2013-12-31 |
Vertex Pharmaceuticals Incorporated |
Heterocikliäśna spojina uporabna kot modulator za prenaĺ alce z atp-vezavno kaseto
|
WO2007055374A1
(ja)
|
2005-11-14 |
2007-05-18 |
Mitsubishi Tanabe Pharma Corporation |
骨粗鬆症治療剤
|
AR057579A1
(es)
|
2005-11-23 |
2007-12-05 |
Merck & Co Inc |
Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
|
BRPI0619252A2
(pt)
|
2005-11-30 |
2011-09-20 |
Vertex Pharma |
inibidores de c-met e seus usos
|
AU2006328602B2
(en)
|
2005-12-23 |
2012-05-31 |
F. Hoffmann-La Roche Ag |
Aryl-isoxazolo-4-yl-oxadiazole derivatives
|
AU2007208494A1
(en)
|
2006-01-12 |
2007-08-02 |
Merck Sharp & Dohme Corp. |
Fluorinated arylamide derivatives
|
WO2007087130A2
(en)
|
2006-01-12 |
2007-08-02 |
Merck & Co., Inc. |
Hydroxyalkylarylamide derivatives
|
TW200813015A
(en)
|
2006-03-15 |
2008-03-16 |
Mitsubishi Pharma Corp |
2-(cyclic amino)-pyrimidone derivatives
|
JP2007283748A
(ja)
|
2006-03-23 |
2007-11-01 |
Fujifilm Corp |
光記録媒体および可視情報記録方法
|
US8445507B2
(en)
|
2006-03-27 |
2013-05-21 |
The Regents Of The University Of California |
Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
|
US8598168B2
(en)
|
2006-04-07 |
2013-12-03 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
JPWO2007125984A1
(ja)
|
2006-04-28 |
2009-09-10 |
日本農薬株式会社 |
イソキサゾリン誘導体及び有害生物防除剤並びにその使用方法
|
JP2009535388A
(ja)
|
2006-05-03 |
2009-10-01 |
アストラゼネカ アクチボラグ |
ピラゾール誘導体、及びそのpi3k阻害薬としての使用
|
WO2007129044A1
(en)
|
2006-05-03 |
2007-11-15 |
Astrazeneca Ab |
Thiazole derivatives and their use as anti-tumour agents
|
US20080064871A1
(en)
|
2006-05-26 |
2008-03-13 |
Japan Tobacco Inc. |
Production Method of Nitrogen-Containing Fused Ring Compounds
|
EA200870592A1
(ru)
|
2006-05-31 |
2009-08-28 |
Галапагос Н.В. |
Триазолопиразиновые соединения, пригодные для лечения дегенеративных и воспалительных заболеваний
|
WO2007143557A2
(en)
|
2006-06-02 |
2007-12-13 |
Brandeis University |
Compounds and methods for treating mammalian gastrointestinal parasitic infections
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
EP2038272B8
(en)
|
2006-06-30 |
2013-10-23 |
Sunesis Pharmaceuticals, Inc. |
Pyridinonyl pdk1 inhibitors
|
US8519135B2
(en)
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
JP2009544611A
(ja)
|
2006-07-20 |
2009-12-17 |
メルク エンド カムパニー インコーポレーテッド |
ヒストン脱アセチル化酵素阻害剤としてのリン誘導体
|
GB0614579D0
(en)
|
2006-07-21 |
2006-08-30 |
Black James Foundation |
Pyrimidine derivatives
|
BRPI0714440A2
(pt)
|
2006-07-21 |
2013-04-24 |
Irm Llc |
composto inibidor de itpkb, uso do mesmo e composiÇço farmacÊutica
|
FR2903985B1
(fr)
|
2006-07-24 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
WO2008013963A2
(en)
|
2006-07-28 |
2008-01-31 |
University Of Connecticut |
Fatty acid amide hydrolase inhibitors
|
WO2008016643A2
(en)
|
2006-08-01 |
2008-02-07 |
Cytokinetics, Incorporated |
Certain chemical entities, compositions, and methods
|
WO2008024970A2
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Tetrahydroindolone and tetrahydroindazolone derivatives
|
US20080119457A1
(en)
|
2006-08-24 |
2008-05-22 |
Serenex, Inc. |
Benzene, Pyridine, and Pyridazine Derivatives
|
CA2663528A1
(en)
|
2006-09-18 |
2008-03-27 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic inhibitors of c-met and uses thereof
|
ES2357340T3
(es)
|
2006-10-18 |
2011-04-25 |
Pfizer Products Inc. |
Compuestos de biaril éter urea.
|
DE102006050515A1
(de)
|
2006-10-26 |
2008-04-30 |
Bayer Healthcare Ag |
Substituierte Dipyridiyl-dihydropyrazolone und ihre Verwendung
|
US7858645B2
(en)
|
2006-11-01 |
2010-12-28 |
Hoffmann-La Roche Inc. |
Indazole derivatives
|
WO2008053913A1
(fr)
|
2006-11-02 |
2008-05-08 |
Shionogi & Co., Ltd. |
Dérivé de sulfonylurée capable d'inhiber sélectivement mmp-13
|
JP2009023986A
(ja)
|
2006-11-08 |
2009-02-05 |
Pharma Ip |
抗癌剤としてのビアリール誘導体
|
US20080145816A1
(en)
|
2006-12-15 |
2008-06-19 |
Hershey Adrienne A |
Yankauer suction device
|
AU2007336281B2
(en)
|
2006-12-21 |
2013-05-30 |
Nerviano Medical Sciences S.R.L. |
Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
|
AR064660A1
(es)
|
2006-12-26 |
2009-04-15 |
Mitsubishi Tanabe Pharma Corp |
Derivados de pirimidinona 6-heterociclica 2-sustituida, medicamentos que los contienen y usos para prevenir y/o tratar enfermedades neurodegenerativas entre otras
|
FR2910473B1
(fr)
|
2006-12-26 |
2009-02-13 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
|
JP2008179068A
(ja)
|
2007-01-25 |
2008-08-07 |
Fujifilm Corp |
光記録媒体および可視情報記録方法
|
JP2008179067A
(ja)
|
2007-01-25 |
2008-08-07 |
Fujifilm Corp |
光記録媒体および可視情報記録方法
|
WO2008092199A1
(en)
|
2007-01-31 |
2008-08-07 |
Cytopia Research Pty Ltd |
Thiopyrimidine-based compounds and uses thereof
|
RS52978B
(sr)
|
2007-03-20 |
2014-02-28 |
Curis, Inc. |
Fuzionisan amino piridin kao hsp90 inhibitori
|
US20080234297A1
(en)
|
2007-03-20 |
2008-09-25 |
Changgeng Qian |
HSP90 Inhibitors Containing a Zinc Binding Moiety
|
US8461343B2
(en)
|
2007-03-27 |
2013-06-11 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of thiohydantoins
|
FR2915198B1
(fr)
|
2007-04-18 |
2009-12-18 |
Sanofi Aventis |
Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
|
CA2684701A1
(en)
|
2007-04-20 |
2008-10-30 |
Biolipox Ab |
Pyrazoles useful in the treatment of inflammation
|
WO2008139152A1
(en)
|
2007-05-11 |
2008-11-20 |
Sentinel Oncology Limited |
N-oxide-containing pharmaceutical compounds
|
EP2162136A4
(en)
|
2007-06-03 |
2012-02-15 |
Univ Vanderbilt |
POSITIVE ALLOSTERIC MGLUR5 BENZAMIDE MODULATORS AND METHOD FOR THEIR PREPARATION AND USE
|
AU2008259804B2
(en)
|
2007-06-05 |
2013-04-18 |
Sanofi-Aventis |
Substituted benzoylamino-indan-2-carboxylic acids and related compounds
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
JP2010531358A
(ja)
|
2007-06-27 |
2010-09-24 |
メルク・シャープ・エンド・ドーム・コーポレイション |
ヒストン脱アセチル化酵素阻害剤としてのピリジル及びピリミジニル誘導体
|
WO2009022171A1
(en)
|
2007-08-13 |
2009-02-19 |
Astrazeneca Ab |
Pyridinyiioxy pyridines as alk5 inhibitors
|
CA2698511C
(en)
|
2007-09-04 |
2016-10-11 |
The Scripps Research Institute |
Substituted pyrimidinyl-amines as protein kinase inhibitors
|
US8354383B2
(en)
|
2007-09-17 |
2013-01-15 |
Enanta Pharmaceuticals, Inc. |
6,11-bridged biaryl macrolides
|
EP2197552B1
(en)
|
2007-09-19 |
2012-11-21 |
4Sc Ag |
Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
|
AU2008300827B2
(en)
|
2007-09-19 |
2013-04-04 |
4Sc Ag |
Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
|
WO2009052319A1
(en)
|
2007-10-16 |
2009-04-23 |
Northeastern University |
Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity
|
US20090156825A1
(en)
|
2007-11-26 |
2009-06-18 |
Heidebrecht Jr Richard W |
Fluorescent compounds that bind to histone deacetylase
|
WO2009078992A1
(en)
|
2007-12-17 |
2009-06-25 |
Amgen Inc. |
Linear tricyclic compounds as p38 kinase inhibitors
|
FR2926553B1
(fr)
|
2008-01-23 |
2010-02-19 |
Sanofi Aventis |
Derives d'indole-2-carboxamides et d'azaindole-2- carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique
|
WO2009100406A2
(en)
|
2008-02-07 |
2009-08-13 |
Synta Pharmaceuticals Corp. |
Topical formulations for the treatment of psoriasis
|
JP2009209090A
(ja)
|
2008-03-04 |
2009-09-17 |
Mitsui Chemicals Inc |
殺虫剤及び該殺虫剤に含まれる化合物、並びに該化合物の使用方法
|
CL2009000600A1
(es)
|
2008-03-20 |
2010-05-07 |
Bayer Cropscience Ag |
Uso de compuestos de diaminopirimidina como agentes fitosanitarios; compuestos de diaminopirimidina; su procedimiento de preparacion; agente que los contiene; procedimiento para la preparacion de dicho agente; y procedimiento para combatir plagas de animales y/u hongos dañinos patogenos de plantas.
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
US8158636B2
(en)
|
2008-05-19 |
2012-04-17 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
US8110576B2
(en)
|
2008-06-10 |
2012-02-07 |
Plexxikon Inc. |
Substituted pyrrolo[2,3b]pyrazines and methods for treatment of raf protein kinase-mediated indications
|
AU2009257635A1
(en)
|
2008-06-10 |
2009-12-17 |
Plexxikon, Inc. |
5H-Pyrrolo [2,3-b] pyrazine derivatives for kinase modulation, and indications therefor
|
EP2303859A4
(en)
|
2008-06-20 |
2012-08-22 |
Metabolex Inc |
ARYL GPR119 AGONISTS AND USES THEREOF
|
AU2009264242A1
(en)
|
2008-06-27 |
2009-12-30 |
Novartis Ag |
Organic compounds
|
KR101345941B1
(ko)
|
2008-07-11 |
2013-12-30 |
아이알엠 엘엘씨 |
Gpr119 활성의 조절제로서의 4-페녹시메틸피페리딘
|
TW201028381A
(en)
|
2008-07-14 |
2010-08-01 |
Shionogi & Co |
Pyridine derivative having ttk inhibition activity
|
EP2548618A3
(en)
|
2008-07-15 |
2013-02-27 |
Novartis AG |
Heteroaryl derivatives as DGAT1 inhibitors
|
EP2334636A2
(en)
|
2008-09-19 |
2011-06-22 |
Pfizer Inc. |
Hydroxamic acid derivatives useful as antibacterial agents
|
UY32146A
(es)
|
2008-09-29 |
2010-04-30 |
Boehringer Ingelheim Int |
Derivados de las 5-[4-(1,5-dimetil-1h-pirazol-4-il)-1,2,3-triazol-1-il]-6-metil-nicotinamidas n-(sustituidas) y de las n-{5-[4-(1,5-dimetil-1h-pirazol-4-il)-1,2,3-triazol-1-il]-6-metil-piridin-3-il}-benzamidas sustituidas y composiciones conteniéndolos
|
WO2010046780A2
(en)
|
2008-10-22 |
2010-04-29 |
Institut Pasteur Korea |
Anti viral compounds
|
US8513242B2
(en)
|
2008-12-12 |
2013-08-20 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimidine compounds and methods of making and using same
|
CN102264737A
(zh)
|
2008-12-23 |
2011-11-30 |
雅培制药有限公司 |
抗病毒化合物
|
WO2010088574A1
(en)
|
2009-01-30 |
2010-08-05 |
Sirtris Pharmaceuticals, Inc. |
Azabenzimidazoles and related analogs as sirtuin modulators
|
WO2010111527A1
(en)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
|
WO2010108921A1
(en)
|
2009-03-27 |
2010-09-30 |
Nerviano Medical Sciences S.R.L. |
N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
|
JP2012522748A
(ja)
|
2009-04-01 |
2012-09-27 |
ノバルティス アーゲー |
ステアロイル−coaデサチュラーゼ調節用スピロ誘導体
|
US8334315B2
(en)
|
2009-05-07 |
2012-12-18 |
Gruenenthal Gmbh |
Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
|
JP2011006408A
(ja)
|
2009-05-29 |
2011-01-13 |
Sumitomo Chemical Co Ltd |
神経栄養因子の活性が関与する疾患の治療または予防剤
|
KR20120031170A
(ko)
|
2009-06-08 |
2012-03-30 |
길리애드 사이언시즈, 인코포레이티드 |
알카노일아미노 벤즈아미드 아닐린 hdac 저해제 화합물
|
WO2010151747A1
(en)
|
2009-06-26 |
2010-12-29 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimine compounds and methods of making and using same
|
WO2011008931A2
(en)
|
2009-07-15 |
2011-01-20 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Arylpyrimidine compounds and combination therapy comprising same for treating cystic fibrosis & related disorders
|
US8415381B2
(en)
|
2009-07-30 |
2013-04-09 |
Novartis Ag |
Heteroaryl compounds and their uses
|
WO2011072275A2
(en)
|
2009-12-11 |
2011-06-16 |
Nono, Inc. |
Agents and methods for treating ischemic and other diseases
|
CN102791731B
(zh)
|
2009-12-16 |
2016-04-20 |
诺沃—诺迪斯克有限公司 |
Glp-1类似物和衍生物
|
WO2011082400A2
(en)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
|
CA2794018C
(en)
|
2010-03-24 |
2016-05-10 |
Medical University Of South Carolina |
Compositions and methods for the treatment of degenerative diseases
|
EP2842944B1
(en)
|
2010-04-06 |
2017-03-15 |
Nippon Soda Co., Ltd. |
Method for producing nitrogen-containing heterocyclic compound
|
EP2560488B1
(en)
|
2010-04-23 |
2015-10-28 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
US8217044B2
(en)
|
2010-04-28 |
2012-07-10 |
Hoffmann-La Roche Inc. |
Spiroindolinone pyrrolidines
|
CN107021951B
(zh)
|
2010-06-30 |
2020-10-20 |
赛克里翁治疗有限公司 |
sGC刺激物
|
US20130109682A1
(en)
|
2010-07-06 |
2013-05-02 |
Novartis Ag |
Cyclic ether compounds useful as kinase inhibitors
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2012024604A2
(en)
|
2010-08-20 |
2012-02-23 |
President And Fellows Of Harvard College |
High-valent palladium fluoride complexes and uses thereof
|
JP2012107001A
(ja)
|
2010-10-22 |
2012-06-07 |
Shionogi & Co Ltd |
インドールアミド化合物を含有する医薬
|
WO2012061337A1
(en)
|
2010-11-02 |
2012-05-10 |
Exelixis, Inc. |
Fgfr2 modulators
|
AU2011326241B2
(en)
|
2010-11-09 |
2016-11-17 |
Ironwood Pharmaceuticals, Inc. |
sGC stimulators
|
WO2012074050A1
(ja)
|
2010-12-01 |
2012-06-07 |
富士フイルム株式会社 |
高分子フィルム、位相差フィルム、偏光板、液晶表示装置、及び化合物
|
CN103328008B
(zh)
|
2010-12-21 |
2016-02-24 |
皇家飞利浦电子股份有限公司 |
用于从循环清除生物分子的试剂
|
US9656959B2
(en)
|
2010-12-22 |
2017-05-23 |
Purdue Pharma L.P. |
Substituted pyridines as sodium channel blockers
|
US20120184572A1
(en)
|
2011-01-13 |
2012-07-19 |
Metabolex, Inc. |
Aryl gpr119 agonists and uses thereof
|
WO2012101062A1
(en)
|
2011-01-28 |
2012-08-02 |
Novartis Ag |
Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
|
US8957066B2
(en)
*
|
2011-02-28 |
2015-02-17 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
US20140057953A1
(en)
|
2011-03-03 |
2014-02-27 |
Rolf Hartmann |
Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors
|
GB201104267D0
(en)
|
2011-03-14 |
2011-04-27 |
Cancer Rec Tech Ltd |
Pyrrolopyridineamino derivatives
|
BR112013023914A2
(pt)
|
2011-03-18 |
2016-12-13 |
Lupin Ltd |
derivados de benzo [b] [1,4] oxazina como moduladores de receptor sensor de cálcio
|
WO2012147890A1
(ja)
|
2011-04-27 |
2012-11-01 |
持田製薬株式会社 |
新規アゾール誘導体
|
WO2012149540A1
(en)
|
2011-04-28 |
2012-11-01 |
The Broad Institute Inc |
Inhibitors of histone deacetylase
|
WO2012154880A1
(en)
|
2011-05-09 |
2012-11-15 |
Proteostasis Therapeutics, Inc. |
Proteostasis regulators for treating cystic fibrosis and other protein misfolding diseases
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
CN108524510A
(zh)
|
2011-05-16 |
2018-09-14 |
皇家飞利浦有限公司 |
生物正交药物活化
|
DK2713722T3
(en)
|
2011-05-31 |
2017-07-03 |
Celgene Int Ii Sarl |
Newly known GLP-1 receptor stabilizers and modulators
|
JP2013020223A
(ja)
|
2011-06-17 |
2013-01-31 |
Fujifilm Corp |
高分子フィルム、セルロースエステルフィルム、偏光板、及び液晶表示装置
|
EP2736882A1
(en)
|
2011-07-26 |
2014-06-04 |
Grünenthal GmbH |
Substituted heterocyclic aza derivatives
|
MX2014000779A
(es)
|
2011-07-26 |
2014-03-27 |
Gruenenthal Gmbh |
Derivados de carboxamida y urea que contienen pirazol heteroaromatico sustituido como ligandos del receptor de vanilloide.
|
WO2013017480A1
(en)
|
2011-07-29 |
2013-02-07 |
Cellzome Limited |
Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors
|
IN2014CN01024A
(sr)
|
2011-08-12 |
2015-04-10 |
Basf Se |
|
KR20140072037A
(ko)
|
2011-08-30 |
2014-06-12 |
씨에이치디아이 파운데이션, 인코포레이티드 |
키뉴레닌-3-모노옥시게나제 억제제, 약학적 조성물 및 이의 사용 방법
|
JP6165733B2
(ja)
|
2011-09-16 |
2017-07-19 |
ノバルティス アーゲー |
N−置換ヘテロシクリルカルボキサミド類
|
BR112014006940A2
(pt)
|
2011-09-23 |
2017-04-04 |
Bayer Ip Gmbh |
uso de derivados de ácido 1-fenilpirazol-3-carboxílico 4-substituído como agentes contra estresse abiótico em plantas
|
EP2899183B1
(en)
|
2011-10-14 |
2018-09-19 |
Bristol-Myers Squibb Company |
Substituted Tetrahydroisoquinoline Compounds as Factor Xia Inhibitors
|
WO2013059648A1
(en)
|
2011-10-21 |
2013-04-25 |
Neurotherapeutics Pharma, Inc. |
2,3,5 trisubstituted aryl and heteroaryl amino derivatives, compositions, and methods of use
|
US9388137B2
(en)
|
2011-10-31 |
2016-07-12 |
Purdue Pharma L.P. |
Quaternized amines as sodium channel blockers
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2013152198A1
(en)
|
2012-04-04 |
2013-10-10 |
Rigel Pharmaceuticals, Inc. |
Protein kinase c inhibitors and uses thereof
|
WO2013152727A1
(en)
|
2012-04-12 |
2013-10-17 |
The University Of Hong Kong |
Platinum(ii) complexes for oled applications
|
US20150105433A1
(en)
|
2012-04-27 |
2015-04-16 |
The Uab Research Foundation |
TREATING VIRAL INFECTIONS HAVING VIRAL RNAs TRANSLATED BY A NON-IRES MEDIATED MECHANISM
|
CN104334552B
(zh)
|
2012-05-31 |
2016-08-31 |
住友化学株式会社 |
稠合杂环化合物
|
US9013997B2
(en)
|
2012-06-01 |
2015-04-21 |
Broadcom Corporation |
System for performing distributed data cut-through
|
SG11201408324QA
(en)
|
2012-06-12 |
2015-01-29 |
Abbvie Inc |
Pyridinone and pyridazinone derivatives
|
EP2861588A4
(en)
|
2012-06-15 |
2016-04-20 |
Univ California |
NEW THERAPEUTIC AGENTS FOR BRAIN CANCER
|
CN103508961B
(zh)
|
2012-06-26 |
2015-07-22 |
中美冠科生物技术(太仓)有限公司 |
抗肿瘤药物
|
WO2014005125A2
(en)
|
2012-06-29 |
2014-01-03 |
Biotium, Inc. |
Fluorescent compounds and uses thereof
|
CN104718213B
(zh)
|
2012-07-18 |
2018-02-27 |
圣母大学 |
5,5‑杂芳族抗感染化合物
|
CN103570625A
(zh)
|
2012-07-19 |
2014-02-12 |
南京英派药业有限公司 |
N-(3-杂芳基芳基)-4-芳基芳基甲酰胺和类似物作为Hedgehog通路抑制剂及其应用
|
US9738623B2
(en)
|
2012-08-06 |
2017-08-22 |
The General Hospital Corporation |
Curcumin analogs
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
US9309235B2
(en)
|
2012-09-18 |
2016-04-12 |
Ironwood Pharmaceuticals, Inc. |
SGC stimulators
|
KR20150072412A
(ko)
|
2012-10-05 |
2015-06-29 |
리겔 파마슈티칼스, 인크. |
Gdf-8 억제제
|
CN104994857A
(zh)
|
2012-10-11 |
2015-10-21 |
格吕伦塔尔有限公司 |
Tspo介导的疾病和/或障碍的治疗和/或预防
|
JP2014101353A
(ja)
|
2012-10-26 |
2014-06-05 |
Shionogi & Co Ltd |
オキサジン誘導体を含有するアルツハイマー症治療用または予防用医薬組成物
|
US9145412B2
(en)
|
2012-11-02 |
2015-09-29 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC1 and HDAC2 inhibitors
|
JP2016502519A
(ja)
|
2012-11-09 |
2016-01-28 |
インディアナ・ユニバーシティ・リサーチ・アンド・テクノロジー・コーポレーション |
Hbv集合エフェクターの代替的使用
|
WO2014081299A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Activatable liposomes
|
FI2922574T3
(fi)
|
2012-11-22 |
2023-08-11 |
Tagworks Pharmaceuticals B V |
Kemiallisesti pilkkoutuva ryhmä
|
WO2014081300A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Channel protein activatable liposomes
|
US20150297741A1
(en)
|
2012-11-22 |
2015-10-22 |
Tagworks Pharmaceuticals B.V. |
Bio-orthogonal drug activation
|
JP6357167B2
(ja)
|
2012-12-04 |
2018-07-11 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
プロテインキナーゼc阻害剤およびそれらの用途
|
CN103864754B
(zh)
|
2012-12-10 |
2016-12-21 |
中国科学院上海药物研究所 |
五元唑类杂环化合物及其制备方法、药物组合物和用途
|
JP6511430B2
(ja)
|
2013-03-11 |
2019-05-15 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
がんの治療のための化合物および組成物
|
WO2014153208A1
(en)
|
2013-03-14 |
2014-09-25 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
US9944644B2
(en)
|
2013-03-14 |
2018-04-17 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles their preparation and use
|
KR20160003647A
(ko)
|
2013-03-15 |
2016-01-11 |
에피자임, 인코포레이티드 |
Carm1 억제제 및 이의 용도
|
KR20150133172A
(ko)
|
2013-03-15 |
2015-11-27 |
셀진 아빌로믹스 리서치, 인코포레이티드 |
Mk2 억제제 및 이의 용도
|
JP6235048B2
(ja)
|
2013-03-20 |
2017-11-22 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
尿素誘導体及びその脂肪酸結合タンパク質(fabp)阻害剤としての使用
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
CN104163791B
(zh)
|
2013-05-20 |
2017-05-03 |
湖南化工研究院 |
N‑吡啶(杂)芳酰胺类化合物及其制备方法与应用
|
CN104163792B
(zh)
|
2013-05-20 |
2017-04-12 |
湖南化工研究院 |
N‑吡啶酰胺类化合物及其制备方法与应用
|
WO2014190199A1
(en)
|
2013-05-24 |
2014-11-27 |
The California Institute For Biomedical Research |
Compounds for treatment of drug resistant and persistent tuberculosis
|
ES2959183T3
(es)
|
2013-05-30 |
2024-02-21 |
Washington University St Louis |
Derivados de manosa y su uso en el tratamiento de infecciones bacterianas
|
JP6603445B2
(ja)
|
2013-06-10 |
2019-11-06 |
アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・アリゾナ・ステイト・ユニバーシティー |
改変された発光スペクトルを有する蛍光性四座配位金属錯体
|
GB2515785A
(en)
|
2013-07-03 |
2015-01-07 |
Redx Pharma Ltd |
Compounds
|
GB2516303A
(en)
|
2013-07-18 |
2015-01-21 |
Redx Pharma Ltd |
Compounds
|
US9359330B2
(en)
|
2013-08-26 |
2016-06-07 |
Purdue Pharma L.P. |
Substituted piperidines as sodium channel blockers
|
WO2015031725A1
(en)
|
2013-08-30 |
2015-03-05 |
President And Fellows Of Harvard College |
Transition metal-catalyzed imidation of arenes
|
MX2016002795A
(es)
|
2013-09-06 |
2016-05-26 |
Inception 2 Inc |
Compuestos de triazolona y usos de los mismos.
|
WO2015051043A1
(en)
|
2013-10-01 |
2015-04-09 |
Amgen Inc. |
Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
|
KR102307387B1
(ko)
|
2013-10-08 |
2021-09-30 |
큉-빈 루 |
표적화된 화학요법에 사용하기 위한 비백금기반 항암 화합물
|
DK3060550T3
(da)
|
2013-10-21 |
2019-07-22 |
Merck Patent Gmbh |
Heteroarylforbindelser som btk-inhibitorer og anvendelser deraf
|
EP3071568A1
(en)
|
2013-11-19 |
2016-09-28 |
Vanderbilt University |
Substituted imidazopyridine and triazolopyridine compounds as negative allosteric modulators of mglur5
|
CN103601718A
(zh)
|
2013-12-05 |
2014-02-26 |
江西天人生态股份有限公司 |
一类基于鱼泥丁受体的邻甲酰氨基苯甲酰胺衍生物及其制备方法和用途
|
WO2015110999A1
(en)
|
2014-01-24 |
2015-07-30 |
Piramal Enterprises Limited |
Ezh2 inhibitors and uses thereof
|
CN103804312B
(zh)
|
2014-02-17 |
2016-04-20 |
四川百利药业有限责任公司 |
一类氮杂环化合物及其制备方法和用途
|
WO2015142903A2
(en)
|
2014-03-17 |
2015-09-24 |
Genentech, Inc. |
Method of controlling lactate production with piperdine-dione derivatives
|
GB201405002D0
(en)
|
2014-03-20 |
2014-05-07 |
Isis Innovation |
Fluorination method
|
US9533982B2
(en)
|
2014-03-20 |
2017-01-03 |
Vanderbilt University |
Substituted bicyclic heteroaryl carboxamide analogs as mGluR5 negative allosteric modulators
|
EP3129350B1
(en)
|
2014-04-09 |
2021-10-27 |
Lumiphore, Inc. |
Macrocycles
|
EP3140298A1
(en)
|
2014-05-07 |
2017-03-15 |
Pfizer Inc. |
Tropomyosin-related kinase inhibitors
|
AU2015270926A1
(en)
*
|
2014-06-02 |
2017-01-05 |
Chdi Foundation, Inc. |
Histone deacetylase inhibitors and compositions and methods of use thereof
|
WO2016018795A1
(en)
|
2014-07-28 |
2016-02-04 |
The General Hospital Corporation |
Histone deacetylase inhibitors
|
US9969744B2
(en)
|
2014-08-04 |
2018-05-15 |
Fundación La Investigación Médica Aplicada |
Compounds for use in cognition improvement
|
CA2958193C
(en)
|
2014-08-18 |
2024-02-27 |
Hudson Biopharma Inc. |
Spiropyrrolidines as mdm2 inhibitors
|
GB201416513D0
(en)
|
2014-09-18 |
2014-11-05 |
Astex Therapeutics Ltd And Cancer Res Technology Ltd |
Pharmaceutical compounds
|
US9550778B2
(en)
|
2014-10-03 |
2017-01-24 |
Vanderbilt University |
Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5
|
CA2963681A1
(en)
|
2014-10-08 |
2016-04-14 |
Acetylon Pharmaceuticals, Inc. |
Induction of gata2 by hdac1 and hdac2 inhibitors
|
MY190408A
(en)
|
2014-10-16 |
2022-04-21 |
Sage Therapeutics Inc |
Compositions and methods for treating cns disorders
|
US10308648B2
(en)
|
2014-10-16 |
2019-06-04 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
WO2016100711A1
(en)
|
2014-12-18 |
2016-06-23 |
The Broad Institute, Inc. |
Modulators of hepatic lipoprotein metabolism
|
CN105777632A
(zh)
|
2015-01-09 |
2016-07-20 |
成都贝斯凯瑞生物科技有限公司 |
芳环并氮杂环衍生物及其应用
|
US9981944B2
(en)
|
2015-02-20 |
2018-05-29 |
Rigel Pharmaceuticals, Inc |
GDF-8 inhibitors
|
US11046692B2
(en)
|
2015-04-30 |
2021-06-29 |
Memorial Sloan-Kettering Cancer Center |
Mitragynine analogs and uses thereof
|
WO2016173557A1
(zh)
|
2015-04-30 |
2016-11-03 |
中国科学院上海药物研究所 |
一类具有激酶抑制活性的化合物、制备方法和用途
|
US10738035B2
(en)
|
2015-05-13 |
2020-08-11 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
US10421756B2
(en)
|
2015-07-06 |
2019-09-24 |
Rodin Therapeutics, Inc. |
Heterobicyclic N-aminophenyl-amides as inhibitors of histone deacetylase
|
PL3319959T3
(pl)
|
2015-07-06 |
2022-02-14 |
Alkermes, Inc. |
Hetero-haloinhibitory deacetylazy histonowej
|
WO2017027984A1
(en)
|
2015-08-20 |
2017-02-23 |
Simon Fraser University |
Compounds and methods for treatment of cancer by inhibiting atg4b and blocking autophagy
|
US10980755B2
(en)
|
2015-09-10 |
2021-04-20 |
The Regents Of The University Of California |
LRH-1 modulators
|
WO2017046133A1
(en)
|
2015-09-14 |
2017-03-23 |
Universiteit Antwerpen |
Process for the catalytic directed cleavage of amide-containing compounds
|
CA3003930A1
(en)
|
2015-11-04 |
2017-05-11 |
Simon Fraser University |
Antibiotic compounds, pharmaceutical formulations thereof and methods and uses therefor
|
TWI773657B
(zh)
|
2015-12-18 |
2022-08-11 |
美商亞德利克斯公司 |
作爲非全身tgr5促效劑之經取代之4-苯基吡啶化合物
|
MD3269370T2
(ro)
|
2016-02-23 |
2020-05-31 |
Taiho Pharmaceutical Co Ltd |
Compus pirimidinic condensat nou sau sare a acestuia
|
DK3426654T3
(en)
|
2016-03-09 |
2022-01-03 |
Harvard College |
Direct palladium-catalyzed aromatic fluorination
|
TWI794171B
(zh)
|
2016-05-11 |
2023-03-01 |
美商滬亞生物國際有限公司 |
Hdac抑制劑與pd-l1抑制劑之組合治療
|
CN110049978A
(zh)
|
2016-11-23 |
2019-07-23 |
雷格南希制药有限责任公司 |
作为选择性hdac1,2抑制剂的哌嗪衍生物
|
JP6756925B2
(ja)
|
2017-01-11 |
2020-09-16 |
ロダン・セラピューティクス,インコーポレーテッド |
ヒストンデアセチラーゼの二環式阻害剤
|
CN106946890A
(zh)
|
2017-04-26 |
2017-07-14 |
中国药科大学 |
吡啶类irak4抑制剂、其制备方法及应用
|
JP7152471B2
(ja)
|
2017-08-07 |
2022-10-12 |
ロダン・セラピューティクス,インコーポレーテッド |
ヒストン脱アセチル化酵素の二環阻害剤
|
AU2019300036A1
(en)
|
2018-07-13 |
2021-01-14 |
Alkermes, Inc. |
Inhibitors of histone deacetylase
|
SG11202012918PA
(en)
|
2018-07-13 |
2021-02-25 |
Alkermes Inc |
Bicyclic inhibitors of histone deacetylase
|